Inventor · disambiguated record
Fernanda Iamassaki Staquicini
Also filed as: STAQUICINI FERNANDA · STAQUICINI FERNANDA I · STAQUICINI FERNANDA IAMASSAKI
6 granted patents·10 pending applications·13 citations·filing 2009–2025
78Inventor score
Files withUNIV RUTGERS8MBRACE THERAPEUTICS INC5STAQUICINI FERNANDA1STAQUICINI FERNANDA I1UNIV TEXAS1
Top patents by PatentIndex Score
16 records- 0193US12180269B2GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78UNIV RUTGERS·Filed 2022·Granted Dec 31, 2024·2 cites·26 claims
- 0293US12103966B2GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78UNIV RUTGERS·Filed 2022·Granted Oct 1, 2024·2 cites·26 claims
- 0384US8450278B2MUC18 targeting peptidesSTAQUICINI FERNANDA·Filed 2009·Granted May 28, 2013·9 cites·15 claims
- 0481US12168685B2Phage-displayed accessible recombinant targeted antibodies and methods of making sameUNIV RUTGERS·Filed 2022·Granted Dec 17, 2024·0 cites·18 claims
- 0578US12060415B2GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodiesUNIV RUTGERS·Filed 2022·Granted Aug 13, 2024·0 cites·26 claims
- 0672US2024115722A1Antibody-Drug Conjugates Against the Receptor Tyrosine Kinase EphA5UNIV RUTGERS·Filed 2023·Application pending·0 cites
- 0769US2023293710A1Antibody-drug conjugates against the receptor tyrosine kinase epha5UNIV RUTGERS·Filed 2022·Application pending·0 cites
- 0865US11254751B2EphA5-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodiesUNIV RUTGERS·Filed 2017·Granted Feb 22, 2022·0 cites·20 claims
- 0965US2023416798A1Methods of recombinant antibody production and related cell systemsMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1063US2024068004A1Cell-free methods of producing antibodies to intracellular targetsMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1163US2024010714A1Cell-free methods of recombinant antibody productionMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1255US2024050580A1Compositions targeting tumor associated macrophages and methods using sameUNIV RUTGERS·Filed 2021·Application pending·0 cites
- 1353US2013296252A1Muc18 targeting peptidesUNIV TEXAS·Filed 2013·Application pending·0 cites
- 1446US2014377288A1Compositions and methods related to dna damage repairSTAQUICINI FERNANDA I·Filed 2012·Application pending·0 cites
- 1542US2025255980A1Antibody-Drug Conjugates Against the Glucose-regulating Protein 78 (GRP78)MBRACE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1641US2025302984A1Antibody-Drug Conjugates Against EPH Receptor A5 (Epha5) for Treatment of CarcinomaMBRACE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →